Galectin Therapeutics (GALT) Cash from Investing Activities (2011 - 2014)

Galectin Therapeutics' Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$400000.0 for Q1 2014.

• In Q1 2014, Cash from Investing Activities changed N/A year-over-year to -$400000.0; the TTM figure through Dec 2014 stood at -$400000.0 (changed N/A YoY), while the FY2014 annual figure was -$400000.0, changed N/A from the prior year.
• Cash from Investing Activities was -$400000.0 for Q1 2014 at Galectin Therapeutics, down from $56000.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $56000.0 in Q4 2012 to a low of -$400000.0 in Q1 2014.
• Historically, Cash from Investing Activities has averaged -$88500.0 across 3 years, with a median of -$5000.0 in 2011.
• Biggest YoY gain for Cash from Investing Activities was 1220.0% in 2012; the steepest drop was 1220.0% in 2012.
• A 3-year view of Cash from Investing Activities shows it stood at -$5000.0 in 2011, then soared by 1220.0% to $56000.0 in 2012, then sank by 814.29% to -$400000.0 in 2014.
• The last three Cash from Investing Activities figures came in at -$400000.0 (Q1 2014), $56000.0 (Q4 2012), and -$5000.0 (Q4 2011), per Business Quant data.